FIELD: organic chemistry, pharmacy. SUBSTANCE: invention claims pharmaceutical composition for oral use prepared by method of humid granulation and comprising N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)- -4-methylpyrazole-3-carboxylic acid amide as active component of the formula: 
, its pharmaceutically acceptable salt or solvate in micronized form taken in the amount 0.5-20 wt.%. Composition comprises 0.05-0.5 wt.% of sodium alkyl sulfate, 2.5-10 wt.% of disaggregating agent and pharmaceutical excipients taken among group including binding agents, diluting agents, dyes, spreading agents, perfumes, lubricating agents, antiadhesive agents, the balance up to 100%. Invention claims also method of pharmaceutical composition preparing. Method involves mixing active component, disaggregating agent and sodium alkyl sulfate with diluting agent, binding agent and, if necessary, with dye at the room temperature. Mixture is wetted with purified water and wet mass is dried and screened by grains size. Then lubricating agent and if necessary antiadhesive agent, spreading agent, dye and/or perfume are added to dries screened grains. Invention ensures to provide the complete dissolving composite and improve kinetics of dissolving. Invention can be used in pharmacy for medicinal agents preparing. EFFECT: improved method of preparing. 10 cl, 7 tbl, 7 ex
